Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare

>>

Global Immune Repertoire Sequencing Market


Global Immune Repertoire Sequencing Market By Product Type [Analytical Software, Assay Kits, Instruments, Services and others],By Application [Autoimmune Diseases, Biomarker Discovery, Cancer Immunotherapy, Infectious Diseases, Transplant Rejection and Tolerance and Vaccine Development and Efficacy], By End User[Diagnostic Labs, Biotechnology and Pharmaceutical Companies, Academic and Research Institutes and Others]: Market Research Report 2021 Covid 19 Impact Outlook, Regional Analysis, Competitive Landscape, Growth Prospects & Forecast -2026

Report code: SDMRHE1566514 | Industry: Healthcare | Published On: 1/1/2021


Global Immune Repertoire Sequencing Market 2020 By Product Type [Analytical Software, Assay Kits, Instruments, Services and others],By Application [Autoimmune Diseases, Biomarker Discovery, Cancer Immunotherapy, Infectious Diseases, Transplant Rejection and Tolerance and Vaccine Development and Efficacy], By End User[Diagnostic Labs, Biotechnology and Pharmaceutical Companies, Academic and Research Institutes and Others]: Global Forecast to 2026 and COVID-19 Impact Outlook
Global Immune Repertoire Sequencing Market is valued at USD 131.2 Million in 2019 and expected to reach USD 215.1 Million by 2026 with the CAGR of 7.33 % over the forecast period.

Scope of the report
This report analyses the global market for Immune Repertoire Sequencing. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.


Key Players

Adaptive Biotechnologies, Agilent Technologies, Inc., ArcherDX, Inc., Atreca, Inc., CD Genomics, Illumina Inc., Oxford Nanopore Technologies, Ltd., Pacific Biosciences, Qiagen N.V., Roche Holding AG, Takara Bio, Inc., Thermo Fisher Scientific, Inc. and others
Above mentioned companies were scrutinized to assess competitive landscape of global Immune Repertoire Sequencing market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.




Review period: (2016-2026)



Historic Period: 2016 to 2019
Forecast Period: 2020 to 2026
Base Year: 2019
Unit: USD Million
This Immune Repertoire Sequencing market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.



Regions


• North America: U.S., Canada and Rest of North America
• Europe: UK, France, Germany, Italy, Spain and Rest of Europe
• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
• Latin America: Brazil, Mexico, Argentina and Rest of Latin America
• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa





Market Segmentation




• Product Type
o Analytical Software
o Assay Kits
o Instruments
o Services
• Application
o Autoimmune Diseases
o Biomarker Discovery
o Cancer Immunotherapy
o Infectious Diseases
o Transplant Rejection and Tolerance
o Vaccine Development and Efficacy
• End User
o Diagnostic Labs
o Biotechnology and Pharmaceutical Companies
o Academic and Research Institutes
o Others






Report Coverage





• An overview of the global Immune Repertoire Sequencing market
• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
• Global Immune Repertoire Sequencing market revenue data historic and forecast analysis (2016 to 2026)
• Characterization and quantification of the market segments for Immune Repertoire Sequencing market
• Market share analysis of key market participants and their competitive landscape
Important Questions Answered by Global Immune Repertoire Sequencing Market Report
• What is the impact of COVID 19 epidemic on the global Immune Repertoire Sequencing market?
• Which is mostly affected region, country?
• Which is the current largest and fastest-growing region?
• What is the market size and growth rate of the global Immune Repertoire Sequencing market?
• What are current factors affecting the growth of market?
• What are Key trends and opportunity areas?
• Within Immune Repertoire Sequencing market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
• What are the major strategies adopted by leading market companies?
• What are company challenges and essential success factors by marketsegment?
• How company offerings and supply chain capabilitiesare shifting to meetemerging market needs?

Table  of  Contents
1.  Introduction
1.1.  Report  Description
1.2.  Market  Segmentation
1.3.  Research  Methodology
1.4.  List  of  Abbreviations
2.  Executive  Summary
3.  Market  Overview
3.1.  Market  Definition  
3.2.  Market  Scope
3.3.  Market  Drivers
3.4.  Market  Restraints
3.5.  Market  Opportunities  and  Trends
3.6.  Porter’s  five  force  analysis
3.7.  SWOT  Analysis
3.8.  PEST  Analysis
3.9.  Patent  Analysis
3.10.  Impact  of  COVID  19  on  Global  Immune  Repertoire  Sequencing  Market
4.  Immune  Repertoire  Sequencing  Market,  By  Product  Type,  Market  Size  and  Forecast  2016  -2026  (USD  Million)
4.1.  Global  Immune  Repertoire  Sequencing  Market  By  Product  Type,  2016  -2026  (USD  Million)
4.1.1.  Global  Immune  Repertoire  Sequencing  Market  By  Analytical  Software
4.1.2.  Global  Immune  Repertoire  Sequencing  Market  By  Assay  Kits
4.1.3.  Global  Immune  Repertoire  Sequencing  Market  By  Instruments  
4.1.4.  Global  Immune  Repertoire  Sequencing  Market  By  Services  
4.2.  Global  Immune  Repertoire  Sequencing  Market  By  Product  Type  Share,  2016  -2026  (%)
5.  Immune  Repertoire  Sequencing  Market,  By  End  User,  Market  Size  and  Forecast  2016  -2026  (USD  Million)
5.1.  Global  Immune  Repertoire  Sequencing  Market  By  End  User,  2016  -2026  (USD  Million)
5.1.1.  Global  Immune  Repertoire  Sequencing  Market  By  Diagnostic  Labs
5.1.2.  Global  Immune  Repertoire  Sequencing  Market  By  Biotechnology  and  Pharmaceutical  Companies
5.1.3.  Global  Immune  Repertoire  Sequencing  Market  By  Academic  and  Research  Institutes
5.1.4.  Global  Immune  Repertoire  Sequencing  Market  By  Others  
5.2.  Global  Immune  Repertoire  Sequencing  Market  By  End  User  Share,  2016  -2026  (%)
6.  Immune  Repertoire  Sequencing  Market,  By  Application,  Market  Size  and  Forecast  2016  -2026  (USD  Million)
6.1.  Global  Immune  Repertoire  Sequencing  Market  By  Application,  2016  -2026  (USD  Million)
6.1.1.  Global  Immune  Repertoire  Sequencing  Market  By  Autoimmune  Diseases
6.1.2.  Global  Immune  Repertoire  Sequencing  Market  By  Biomarker  Discovery
6.1.3.  Global  Immune  Repertoire  Sequencing  Market  By  Cancer  Immunotherapy
6.1.4.  Global  Immune  Repertoire  Sequencing  Market  By  Infectious  Diseases  
6.1.5.  Global  Immune  Repertoire  Sequencing  Market  By  Transplant  Rejection  and  Tolerance
6.1.6.  Global  Immune  Repertoire  Sequencing  Market  By  Vaccine  Development  and  Efficacy
6.2.  Global  Immune  Repertoire  Sequencing  Market  By  Application  Share,  2016  -2026  (%)
7.  Immune  Repertoire  Sequencing  Market,  By  Region  Market  Size  and  Forecast  2016  -2026
7.1.  NORTH  AMERICA
7.1.1.  Key  Findings
7.1.2.  Impact  of  COVID  19
7.1.3.  Key  market  trends,  growth  factors  and  opportunities
7.1.4.  North  America  Immune  Repertoire  Sequencing  Market  by  Country  2016  -2026  (USD  Million)
7.1.5.  North  America  Immune  Repertoire  Sequencing  Market  By  Product  Type  2016  -2026  (USD  Million)
7.1.6.  North  America  Immune  Repertoire  Sequencing  Market  By  Application  2016  -2026  (USD  Million)
7.1.7.  North  America  Immune  Repertoire  Sequencing  Market  By  End  User  2016  -2026  (USD  Million)
7.2.  EUROPE
7.2.1.  Key  Findings
7.2.2.  Impact  of  COVID  19
7.2.3.  Key  market  trends,  growth  factors  and  opportunities
7.2.4.  Europe  Immune  Repertoire  Sequencing  Market  by  Country  2016  -2026  (USD  Million)
7.2.5.  Europe  Immune  Repertoire  Sequencing  Market  By  Product  Type  2016  -2026  (USD  Million)
7.2.6.  Europe  Immune  Repertoire  Sequencing  Market  By  Application  2016  -2026  (USD  Million)
7.2.7.  Europe  Immune  Repertoire  Sequencing  Market  By  End  User  2016  -2026  (USD  Million)
7.3.  ASIA  PACIFIC
7.3.1.  Key  Findings
7.3.2.  Impact  of  COVID  19
7.3.3.  Key  market  trends,  growth  factors  and  opportunities
7.3.4.  Asia  Pacific  Immune  Repertoire  Sequencing  Market  by  Country  2016  -2026  (USD  Million)
7.3.5.  Asia  Pacific  Immune  Repertoire  Sequencing  Market  By  Product  Type  2016  -2026  (USD  Million)
7.3.6.  Asia  Pacific  Immune  Repertoire  Sequencing  Market  By  Application  2016  -2026  (USD  Million)
7.3.7.  Asia  Pacific  Immune  Repertoire  Sequencing  Market  By  End  User  2016  -2026  (USD  Million)
7.4.  LATIN  AMERICA
7.4.1.  Key  Findings
7.4.2.  Impact  of  COVID  19
7.4.3.  Key  market  trends,  growth  factors  and  opportunities
7.4.4.  Latin  America  Immune  Repertoire  Sequencing  Market  by  Country  2016  -2026  (USD  Million)
7.4.5.  Latin  America  Immune  Repertoire  Sequencing  Market  By  Product  Type  2016  -2026  (USD  Million)
7.4.6.  Latin  America  Immune  Repertoire  Sequencing  Market  By  Application  2016  -2026  (USD  Million)
7.4.7.  Latin  America  Immune  Repertoire  Sequencing  Market  By  End  User  2016  -2026  (USD  Million)
7.5.  MIDDLE  EAST  AND  AFRICA
7.5.1.  Key  Findings
7.5.2.  Impact  of  COVID  19
7.5.3.  Key  market  trends,  growth  factors  and  opportunities
7.5.4.  Middle  East  and  Africa  Immune  Repertoire  Sequencing  Market  by  Country  2016  -2026  (USD  Million)
7.5.5.  Middle  East  and  Africa  Immune  Repertoire  Sequencing  Market  By  Product  Type  2016  -2026  (USD  Million)
7.5.6.  Middle  East  and  Africa  Immune  Repertoire  Sequencing  Market  By  Application  2016  -2026  (USD  Million)
7.5.7.  Middle  East  and  Africa  Immune  Repertoire  Sequencing  Market  By  End  User  2016  -2026  (USD  Million)
8.  Competitive  Landscape  Analysis
8.1.  Global  Immune  Repertoire  Sequencing  Market  Company  Revenue,  (USD  Million),  2016-2019
8.2.  Global  Immune  Repertoire  Sequencing  Market  Company  Share,  (%),  2016-2019
9.  Company  Profiles
9.1.  Adaptive  Biotechnologies
9.2.  Agilent  Technologies,  Inc.
9.3.  ArcherDX,  Inc.
9.4.  Atreca,  Inc.
9.5.  CD  Genomics
9.6.  Illumina  Inc.
9.7.  Oxford  Nanopore  Technologies,  Ltd.
9.8.  Pacific  Biosciences
9.9.  Qiagen  N.V.
9.10.  Roche  Holding  AG
9.11.  Takara  Bio,  Inc.
9.12.  Thermo  Fisher  Scientific,  Inc.
9.13.  Others  

10.  Appendix
11.  List  of  Tables  
12.  List  of  Figures  



 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT